Início/Ações/RZLT

RZLT

USD

Rezolute Inc. Common Stock (NV)

$8.900-0.020 (-0.224%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$8.920

Máximo

$9.000

Mínimo

$8.820

Volume

1.64M

Fundamentos da empresa

Capitalização de mercado

808.4M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

1.24M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $2.215Atual $8.900Máximo $10.04

Notícias relacionadas

29/10/2025 · 16:02

Analyst Upgrades

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17

Citizens analyst Jason N. Butler maintains Rezolute with a Market Outperform and raises the price target from $9 to $17.

Ver mais

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17

15/10/2025 · 12:00

GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

Ver mais

Rezolute to Participate in Upcoming Investor Conferences

9/10/2025 · 20:05

GlobeNewswire

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

Ver mais